Publicaciones en las que colabora con MONICA IMBERNON PIEDRA (12)

2019

  1. MCH regulates SIRT1/FoxO1 and reduces POMC neuronal activity to induce hyperphagia, adiposity, and glucose intolerance

    Diabetes, Vol. 68, Núm. 12, pp. 2210-2222

2018

  1. Melanin-Concentrating Hormone acts through hypothalamic kappa opioid system and p70S6K to stimulate acute food intake

    Neuropharmacology, Vol. 130, pp. 62-70

2017

  1. Corrigendum: Hepatic p63 regulates steatosis via IKKβ/ER stress

    Nature communications

  2. Gpr55: A new promising target for metabolism?

    Journal of Molecular Endocrinology, Vol. 58, Núm. 3, pp. R191-R202

  3. Hepatic p63 regulates steatosis via IKKβ/ER stress

    Nature Communications, Vol. 8

2016

  1. Hypothalamic kappa opioid receptor mediates both diet-induced and melanin concentrating hormone–induced liver damage through inflammation and endoplasmic reticulum stress

    Hepatology, Vol. 64, Núm. 4, pp. 1086-1104

2014

  1. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK

    Diabetes, Vol. 63, Núm. 10, pp. 3346-3358

  2. Hypothalamic KLF4 mediates leptin's effects on food intake via AgRP

    Molecular Metabolism, Vol. 3, Núm. 4, pp. 441-451

  3. Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors

    Molecular and Cellular Endocrinology, Vol. 383, Núm. 1-2, pp. 159-169

2013

  1. Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways

    Gastroenterology, Vol. 144, Núm. 3

2012

  1. The L-α-Lysophosphatidylinositol/GPR55 System and its potential role in human obesity

    Diabetes, Vol. 61, Núm. 2, pp. 281-291

2011

  1. Role for the putative cannabinoid receptor GPR55 in the islets of Langerhans

    Journal of Endocrinology, Vol. 211, Núm. 2, pp. 177-185